External Research Program

Healthcare professionals

Overview

Thank you for your interest in Royal Biologics’ Clinical Affairs Research Collaboration Program.

This initiative is designed to foster meaningful clinical research by supporting independent, investigator-led studies that explore the use and effectiveness of our biologic products and regenerative therapies. Our goal is to collaborate with healthcare professionals in generating scientific evidence that can improve clinical outcomes and drive innovation in orthobiologics and acute and chronic wound care.

About the program

As clinical evidence becomes a cornerstone of innovation in modern medicine, Royal Biologics is proud to support this evolution through our Clinical Affairs Research Collaboration Program. This program welcomes investigator-led research initiatives that align with our commitment to science-backed solutions and patient-focused care.

If you’re a Sponsor-Investigator conducting independent research involving our products, this program may be a fit. If you’re unsure whether your inquiry qualifies under this program or is more suited for a general research grant, feel free to reach out using the contact information below.

Does My Request Qualify?

Use the table below to determine whether your research proposal aligns with our ClinicalAffairs Research Collaboration Program:

Is There a Protocol?	Is There a Sponsor-Investigator?	Is It Focused on a Royal Biologics Product or Therapy?	Program
Yes	Yes	Yes	Eligible for Collaboration Program
N/A	N/A	N/A	May qualify for General Research Grant

For more details about general research grants, please contact us directly.

KEY DEFINITIONS

Sponsor
An institution or organization responsible for the initiation, oversight, and/or funding of a clinical study.

Principal Investigator
The individual who conducts the study at a specific site and ensures scientific and ethical integrity.

Sponsor-Investigator
A single individual who both initiates and conducts the study, assuming full responsibility for its execution and regulatory compliance.

Note: Regulatory responsibilities and terms may vary based on location.

Roles & Responsibilities

When participating in the Royal Biologics research collaboration program:

The Sponsor-Investigator is fully accountable for study design, regulatory compliance, IRB approvals, data integrity, and publication efforts.
Royal Biologics may offer support through product supply, funding, or consultation, but we do not act as the study sponsor and will not influence study design, execution, or outcome reporting.

Investigator-Led vs. Industry-Sponsored Studies

Category	Industry-Sponsored Study	Investigator-Initiated Study
Protocol Ownership	Royal Biologics designs and manages the protocol.	Investigator designs and owns the protocol.
Data Control	Royal Biologics manages and analyzes the data.	Investigator oversees data and grants Royal Biologics access as needed.
Monitoring	Monitoring conducted by Royal Biologics.	Investigator ensures proper conduct and data quality.
IP Rights	Typically owned by Royal Biologics.	Rights may remain with the investigator or be shared.
Deliverables	Determined by Royal Biologics.	Defined collaboratively in research agreement.
Publications	Authorship and dissemination managed by sponsor.	Investigator determines authorship and publication strategy.

Get in Touch

If you have questions or would like to discuss a potential research project, please contact our Medical Affairs Team